Previous Page  10 / 14 Next Page
Information
Show Menu
Previous Page 10 / 14 Next Page
Page Background

Volume 8

Journal of Biotechnology & Biomaterials

ISSN: 2155-952X

Biotech Congress 2018 & Enzymology 2018

March 05-07, 2018

Page 56

Notes:

conference

series

.com

JOINT EVENT

20

th

Global Congress on

Biotechnology

3

rd

International Conference on

Enzymology and Molecular Biology

&

March 05-07, 2018 London, UK

Sergey Suchkov, J Biotechnol Biomater 2018, Volume 8

DOI: 10.4172/2155-952X-C2-090

Principles of profiling as applicable to the infrastructure of continuous education system to impact

for having drug design to suit an innovative model of translational pipeline

P

ersonalized medicine (PM) as the healthcare of the future represents an innovative model for advanced healthcare and

robust platform for relevant industrial branches for diagnostics and pharmaceutics. However, rapid market penetration

of new technologies demands the implementation of reforms not only in biopharma, but also in education. Therefore, the

problem of the updated education of specialists in bioengineering, drug design and affiliated fields is becoming particularly

urgent, and it requires significant revision of newer programs and curricula to be updated. Modernization and integration of

widely accepted standards require consolidation of both the natural and medical sciences that may become the conceptual

basis for the biopharma education. The main goal of this training is to provide development of novel multifaceted approaches

to build academic schools for future generations. So, a higher, secondary and primary education as a trio should be integrated

into the circuit. Based on current trends and own experience, we have made the first steps towards reshuffling the canonical

educational tandem “School-University” and restructuring of specialized groups (with targeted disciplines) to get the mentees

to be involved into having the existing healthcare system advanced and stepped forward. Moreover, non-canonical approach

has been used to create a team of young researchers and biopharma students which has been recognized as The International

Research Team of Youngsters under the aegis of EPMA (Brussels, EU) and ISPM (Tokyo, Japan). The integration of the primary

and secondary education provides: 1. development in the chosen direction; and 2. optimization of the jointly set activity of a

student and the teacher within a pair or a tandem (mentor-mentee). The above-mentioned has pre-determining value, because

under the disintegration of the world community expressed the competition in quality of the scientific intellect dramatically

increases. The same occurs in the areas of quality of all of three segments of the educational process, i.e., pre-college (secondary

school), university and graduate.

Biography

Sergey Suchkov graduated from Astrakhan State Medical University and awarded with MD, In 1985 he completed his Ph.D. at I M Sechenov Moscow Medical Academy

and in 2001, maintained his Doctorship Degree at the Nat Inst of Immunology, Russia. From 1987 through 1989, he was a senior Researcher, Koltzov Inst of Developmen-

tal Biology. From 1989 through 1995, he was a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, he was a

Chair of the Dept. for Clinical Immunology, Moscow Clinical Research Institute. He has been trained at: NIH; Wills Eye Hospital, PA, USA; Univ. of Florida in Gainesville;

UCSF, S-F, CA, USA; Johns Hopkins University, Baltimore, MD, USA. He was an Exe Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal

published jointly by the USSRAcademy of Sci-ences and the Royal Society of Chemistry, UK. At present, he is a Chair, Dept. for Personalized and Translational Medicine,

I M Sechenov First Moscow State Medical University. He is a member of the New York Academy of Sciences, USA; American Chemical Society (ACS), USA; American

Heart Association (AHA), USA; EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ARVO (American Association for Re-

search in Vision and Ophthalmology); ISER (International Society for Eye Re-search); PMC (Personalized Medicine Coalition), Washington, USA.

ssuchkov57@gmail.com

Sergey Suchkov

I M Sechenov First Moscow State Medical University, Russia